The patent for our invention: “Methods for target-based drug screening through numerical inversion of quantitative structure-drug performance relationships and molecular dynamics simulations” (J. Jay Liu, Myunggi Yi, Petar Žuvela) has been granted by the Korean patent office. PCT is still pending. The corresponding publication can be found at the following link.
